HQ PHARMA

HQ PHARMA was founded in 2016 as a pharmaceutical R&D enterprise focused on high-end modified formulations. The company is committed to following the example of America's "ALZA" and becoming a global leader in Drug Delivery System (DDS) research and development, aspiring to empower human health through pharmaceutical technology innovation. HQ PHARMA has established laboratories in Zibo, Shandong (1800㎡) and Jiading, Shanghai (8200㎡), which include pilot workshops, advanced formulation labs, and high-potency drug labs. Additionally, it has deployed clinical operations and registration teams across multiple locations worldwide, dedicated to providing compliant and efficient R&D and submission services for innovative reformulations, pediatric drugs, and generic drugs for enterprises both in China and overseas.